Oral question asked in the House of Lords, by Lord Addington (Liberal Democrat). It was answered by Lord Hunt of Kings Heath (Labour) on Wednesday, 7 March 2001.
Hunt of Kings Heath, Lord
- Question
- Whether the National Institute for Clinical Excellence (NICE), in assessing the cost-effectiveness of disease-modifying drugs in multiple sclerosis, will take into account all relevant cost savings to health and social services and the social security system.
Secondary information
- Type
- Oral question
- Reference
- 623 c202
- Session
- 2000-01
- Oral question type
- Lead
- Chamber / Committee
- House of Lords chamber
- Subjects
- Cost effectiveness Health services Drugs Medical treatments Multiple sclerosis Social services National Institute for Clinical Excellence
Librarians' tools
- Timestamp
- 2026-09-30 15:18:35 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_833388
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_833388
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_833388